Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Managing Impella® Position Using Imaging and the Automated Impella Controller™

Jo Kajewski, advanced Impella trainer, discusses how Impella should appear on baseline echo and steps for repositioning Impella if a positioning alarm occur. 

Discover New Data on Protected PCI versus Bailout PCI

Alexander Truesdell, MD, discusses Protected PCI versus bailout PCI using data from the cVAD Study and the PROTECT III study. 

Techniques to Reduce Bleeding with Large Bore Access Devices

Amir Kaki, MD, discusses techniques and best practices for access and closure to reduce bleeding and complications with large-bore access devices.

Looking to Clinical Evidence in Cardiogenic Shock

William O’Neill, MD discusses cardiogenic shock treatment in light of the lack of randomized, controlled clinical trial data for cardiogenic shock.

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.

Assessing Impella® Heart Pump Position with Echocardiography

Echocardiography for assessing Impella position—a discussion with Clinical Support Specialist Michael Galvin, RDCS.

Right Heart Failure and the Impella RP® with SmartAssist® Heart Pump

This FAQ discusses the causes, incidence, and diagnosis of right heart failure and how the Impella RP with SmartAssist heart pump can support the right side of the heart.

What is the purpose of the STEMI DTU™ RCT?

This FAQ provides key information about the purpose and design of the STEMI DTU pivotal randomized controlled trial and how to participate.

FAQ: What Is the Clinical Evidence That Supports the Benefit of Placing the Impella® Heart Pump Pre-PCI?

A preponderance of evidence from the FDA cVAD Study, Impella Quality Database and the physician-initiated NSCI study supports the recommendation that placing Impella 2.5® or Impella CP® pre-PCI improves outcomes.

Data from the NCSI Study Demonstrates 72% Survival with 98% Native Heart Recovery

William O'Neill, MD, discusses data from the National Cardiogenic Shock Initiative (NCSI) study presented at the 2019 SCAI Scientific Sessions.

Protected PCI with Impella® and Intravascular Lithotripsy with Shockwave

Robert Riley, MD, presents a high-risk PCI case requiring hemodynamic support with the Impella CP® heart pump and intravascular lithotripsy with Shockwave for vascular access.

Discussion of a Retrospective Matched-Pair Analysis Comparing Patients in Cardiogenic Shock Treated with Balloon Pump and the Impella® Heart Pump

Seth Bilazarian, MD, discusses the limitations of Schrage, Ibrahim, et al. published in Circulation comparing patients in cardiogenic shock treated with balloon pump and the Impella® heart pump. 

What is the STEMI DTU™ Pilot Trial?

The STEMI DTU pilot trial demonstrated for the first time that LV unloading using the Impella CP® heart pump with a 30-minute delay before reperfusion is safe and feasible

Complex PCI Involving Prior CABG and Comorbidities

Perwaiz Meraj, MD, presents a complex coronary intervention Protected PCI case with hemodynamic support from the Impella CP® heart pump. 

Training Video for the Axillary Insertion Kit

This Quick Skills Video depicts insertion of the Impella 5.0 with the Axillary Insertion Kit.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].